Search results
Showing 8341 to 8355 of 8905 results
Workplace health: long-term sickness absence and incapacity to work (PH19)
This guideline has been updated and replaced by NICE guideline NG146.
Four commonly used methods to increase physical activity (PH2)
This guideline covered four common methods used to increase the population's physical activity levels: brief interventions in primary care, exercise referral schemes, pedometers and community-based walking and cycling programmes. It has been updated and replaced by the following NICE guidelines: Walking and cycling (2012) PH41 Physical activity: brief advice for adults in primary care (2013) PH44 Exercise referral schemes to promote physical activity (2014) PH54
Social and emotional wellbeing in secondary education (PH20)
This guideline has been updated and replaced by NICE guideline on social, emotional and mental wellbeing in primary and secondary education (NG223).
Immunisations: reducing differences in uptake in under 19s (PH21)
This guideline has been replaced by NICE guideline NG218.
This guideline has been updated and replaced by NICE guideline NG212.
This guidance has been updated and replaced by NICE guideline NG92.
This guideline has been updated and replaced by NICE guideline NG247.
Smoking: preventing uptake in children and young people (PH14)
This guideline has been updated and replaced by the NICE guideline on tobacco: preventing uptake, promoting quitting and treating dependence (NG209).
This guideline has been updated and replaced by NICE guideline NG92.
This guideline has been updated and replaced by the NICE guideline on social, emotional and mental wellbeing in primary and secondary education (NG223).
Gantenerumab for treating early Alzheimer's disease [ID6142]
In development Reference number: GID-TA11269 Expected publication date: TBC
In development Reference number: GID-TA11251 Expected publication date: TBC
Giroctocogene fitelparvovec for treating moderately severe to severe haemophilia A [ID6312]
In development Reference number: GID-TA11329 Expected publication date: TBC
In development Reference number: GID-TA11805 Expected publication date: TBC
Eteplirsen for treating Duchenne muscular dystrophy [ID1003]
Discontinued Reference number: GID-HST10007